Cargando…
Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19
BACKGROUND: For cancer patients, coronavirus disease 19 (COVID‐19) infection can lead to delays in cancer therapy both due to the infection itself and due to the need to minimize exposure to other patients and to staff. Clearance guidelines have been proposed, but expected time to clearance has not...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940218/ https://www.ncbi.nlm.nih.gov/pubmed/33560590 http://dx.doi.org/10.1002/cam4.3708 |